文献速递关节外科

假体真菌感染:合并细菌感染时预后不良

Prosthetic fungal infections: poor prognosis with bacterial co-infection.
PubMed 文献 · Bone Joint J · 2019-01-01

该研究回顾性分析了2006至2015年间在单一骨感染中心治疗的22例细菌与真菌共感染假体周围关节感染(PJI)患者,占全部PJI的1.85%。所有患者均行两阶段翻修,总体感染根除率在2年时为50%(95%CI 32.9-75.9),5年时为38.9%(95%CI 22.6-67)。多药耐药细菌、就诊时较高的C反应蛋白及共感染细菌种类多与复发感染风险显著升高相关。

要点

  • 细菌与真菌共感染PJI占全部PJI的1.85%,均为两阶段翻修。
  • 2年感染根除率50%,5年降至38.9%(95%CI 22.6-67)。
  • 多药耐药细菌、高CRP及多种共感染细菌与复发风险升高相关。

核心结论

  • 该诊断下感染根除失败并需截肢的风险远高于无细菌真菌共感染的PJI患者,当真菌合并多种微生物及多药耐药细菌时风险更高。

研究设计与样本

  • 回顾性研究,于2006至2015年在单一骨感染中心治疗1189例PJI患者,纳入22例(1.85%)细菌与真菌共感染PJI,其中女9例、男13例,诊断时平均年龄64.5岁(47-83),平均BMI 30.9 kg/m2(24-42)。
  • 8例全髋关节置换术后和14例全膝关节置换术后PJI,平均临床随访4.1年(1.4-8.8)。

主要发现

  • PJI危险因素中位数5.5个(IQR 3.25-7.25)。
  • 初始行清创保留假体(DAIR)的7例患者全部复发感染,均转为分期翻修。
  • 22例患者均行两阶段翻修的第一阶段。
  • 第二阶段组织培养阴性的9例患者均无复发感染。
  • 多药耐药细菌(p=0.007)、就诊时较高的CRP(p=0.032)及共感染细菌种类多(p=0.041)与复发感染率显著升高相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aims of this study were to report the efficacy of revision surgery for patients with co-infective bacterial and fungal prosthetic joint infections (PJIs) presenting to a single institution, and to identify prognostic factors that would guide management. PATIENTS AND METHODS: A total of 1189 patients with a PJI were managed in our bone infection service between 2006 and 2015; 22 (1.85%) with co-infective bacterial and fungal PJI were included in the study. There were nine women and 13 men, with a mean age at the time of diagnosis of 64.5 years (47 to 83). Their mean BMI was 30.9 kg/m2 (24 to 42). We retrospectively reviewed the outcomes of these PJIs, after eight total hip arthroplasties and 14 total knee arthroplasties. The mean clinical follow-up was 4.1 years (1.4 to 8.8). RESULTS: The median number of risk factors for PJI was 5.5 (interquartile range (IQR) 3.25 to 7.25). All seven patients who initially underwent debridement and implant retention (DAIR) had a recurrent infection that led to a staged revision. All 22 patients underwent the first of a two-stage revision. None of the nine patients with negative tissue cultures at the second stage had a recurrent infection. The rate of recurrent infection was significantly higher in the presence of multidrug-resistant bacteria (p = 0.007), a higher C-reactive protein (CRP) at the time of presentation (p = 0.032), and a higher number of co-infective bacterial organisms (p = 0.041). The overall rate of eradication of infection after two and five years was 50% (95% confidence interval (CI) 32.9 to 75.9) and 38.9% (95% CI 22.6 to 67), respectively. CONCLUSION: The risk of failure to eradicate infection with the requirement of amputation associated with this diagnosis is much higher than in patients with PJI without bacterial and fungal co-infection, and this risk is heightened when the fungal organism is joined by polymicrobial and multidrug-resistant bacterial organisms. Cite this article: Bone Joint J 2019;101-B:582-588.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Sidhu MS, Cooper G, Jenkins N, et al. Prosthetic fungal infections: poor prognosis with bacterial co-infection. Bone Joint J. 2019. PMID: 31039037. doi:10.1302/0301-620X.101B5.BJJ-2018-1202.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。